Chari Ravi S. 4

Accession 0001209191-18-007219

CIK 0000860730other

View on SEC.gov Company Profile

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 7:33 PM ET

Size

36.6 KB

Accession

0001209191-18-007219

Insider Transaction Report

Form 4

Period: 2018-01-31

HCA Healthcare, Inc.HCA

Chari Ravi S.

SVP-Clinical Excellence

Transactions

Sale
Common Stock
2018-02-02$102.01/sh−5,702$581,655→ 0 total
Exercise/Conversion
Stock Appreciation Right
2018-01-31−1,750→ 1,750 total
Exercise: $47.97Exp: 2024-02-05→ Common Stock (1,750 underlying)
Sale
Common Stock
2018-02-01$103.08/sh−568.053$58,555→ 5,702 total
Exercise/Conversion
Stock Appreciation Right
2018-01-31−2,125→ 0 total
Exercise: $37.18Exp: 2023-02-06→ Common Stock (2,125 underlying)
Exercise/Conversion
Stock Appreciation Right
2018-01-31−2,750→ 5,500 total
Exercise: $68.96Exp: 2025-02-04→ Common Stock (2,750 underlying)
Exercise/Conversion
Common Stock
2018-01-31$47.97/sh+3,150$151,106→ 8,332.053 total
Award
Stock Appreciation Right
2018-01-31+18,300→ 18,300 total
Exercise: $101.16From: 2019-01-31Exp: 2028-01-31→ Common Stock (18,300 underlying)
Exercise/Conversion
Common Stock
2018-01-31$37.18/sh+3,825$142,214→ 5,182.053 total
Exercise/Conversion
Common Stock
2018-01-31$68.96/sh+2,750$189,640→ 11,082.053 total
Exercise/Conversion
Common Stock
2018-01-31$69.58/sh+5,125$356,598→ 16,207.053 total
Tax Payment
Common Stock
2018-01-31$101.16/sh−9,937$1,005,227→ 6,270.053 total
Sale
Common Stock
2018-02-01$101.50/sh−10,000$1,015,000→ 0 total(indirect: By Trust)
Exercise/Conversion
Stock Appreciation Right
2018-01-31−1,700→ 0 total
Exercise: $37.18Exp: 2023-02-06→ Common Stock (1,700 underlying)
Exercise/Conversion
Stock Appreciation Right
2018-01-31−1,400→ 0 total
Exercise: $47.97Exp: 2024-02-05→ Common Stock (1,400 underlying)
Exercise/Conversion
Stock Appreciation Right
2018-01-31−5,125→ 5,125 total
Exercise: $69.58Exp: 2026-01-29→ Common Stock (5,125 underlying)

Footnotes (9)

[F1]Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.00 to $102.041, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014.
[F4]The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.
[F5]The stock appreciation rights vested at the end of fiscal year 2016 based upon the achievement of certain annual EBITDA performance targets.
[F6]The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015.
[F7]The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016.
[F8]The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017.
[F9]The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019.

Documents

2 files

Issuer

HCA Healthcare, Inc.

CIK 0000860730

→

Entity typeother

Related Parties

filerCIK 0001632795

Filing Metadata

Form type: 4
Filed: Feb 1, 7:00 PM ET
Accepted: Feb 2, 7:33 PM ET
Size: 36.6 KB

View on SEC.gov